Calvin Sternick

Stock Analyst at JP Morgan

(2.03)
# 3,050
Out of 5,154 analysts
19
Total ratings
46.15%
Success rate
7.12%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $81.09
Upside: +35.65%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $43.65
Upside: +83.28%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $34.28
Upside: -21.24%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $192.65
Upside: -5.53%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $236.95
Upside: -65.82%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $144.47
Upside: +171.34%